Combining targeted biological agents with radiotherapy : current status and future directions /
Radiotherapy plays an integral role in cancer treatment. Approximately 60% of cancer patients will receive radiotherapy at some point in their treatment. A major improvement in patient outcomes occurs with the use of combined chemotherapy and radiotherapy. The combination of targeted biological agen...
| Други автори: | Small, William, Jr. |
|---|---|
| Формат: | Електронна книга |
| Език: | English |
| Публикувано: |
New York :
Demos Medical Pub.,
℗♭2008.
|
| Предмети: | |
| Онлайн достъп: |
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=237613 |
| Подобни документи: |
Print version::
Combining targeted biological agents with radiotherapy. |
Съдържание:
- Targeted therapies: definitions, limitations, and future directions / Tamara Z .Vern and William Small Jr.
- Epidermal growth factor receptors (EGFR) / Michael P. Hagan [and others]
- Vascular epithelial growth factor (VEGF) receptors / Andrew N. Fontanella, Yiting Cao, and Mark W. Dewhirst.
- Dermatologic manifestations of targeted therapies / Mario E. Lacouture, Bharat B. Mittal, and Mark Agulnik
- Radiolabeled monoclonal antibody therapies / Lanea M.M. Keller [and others]
- Targeted therapies in malignant gliomas / Sean Grimm
- Targeted therapies in head and neck cancer / Ranee Mehra, Roger B. Cohen, and Paul M. Harari.
- Targeted therapies in lung cancer / Gregory M.M. Videtic
- Targeted therapies in pancreatic cancer / Sunil Krishnan, Vishal Rana, and Christopher H. Crane
- Targeted therapies in cervical cancer / Christopher J. Anker and David K. Gaffney
- Targeted therapies in endometrial cancer / Jergin Chen and David K. Gaffney.